Gunting, Baby Girl P.

HRN: 21-89-47  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
AMPICILLIN 1GM (VIAL)
09/14/2022
09/20/2022
IV
240mg
Q8
Neonatal Sepsis
Waiting Final Action 
09/14/2022
CEFOTAXIME 500MG (VIAL)
09/14/2022
09/20/2022
IV
185mg
Q8
Neonatal Sepsis
Waiting Final Action 
09/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/15/2022
09/22/2022
IV
28mg
Q6hours
Neonatal Sepsis
Waiting Final Action 
09/17/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/17/2022
09/24/2022
IV
50 Mg
Q24H
Neonatal Sepsis
Waiting Final Action 
09/17/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/17/2022
09/24/2022
IV
370 Mg
Q6H
Neonatal Sepsis
Waiting Final Action 
09/23/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/23/2022
09/30/2022
IV
28mg
Q6H
Neonatal Sepsis
Waiting Final Action 
10/02/2022
CIPROFLOXACIN 500MG (TAB)
10/02/2022
10/09/2022
PER OGT
30mg/pptab
Q12
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: